中国临床药学杂志

参考文献

[1] ROTELLI M T,BOCALE D,De FAZIO M,et al. In-vitro evidence for the protective properties of the main components of the Mediterranean diet against colorectal cancer:a systematic review[J]. Surg Oncol,2015,24(3):145.

[2] SOLEAS G J,DIAMANDIS E P,GOLDBERG D M.Resveratrol: a molecule whose time has come and gone[J]. Clin Biochem,1997,30(2):91.

[3] JANG M, CAI L, MEHTA R G,et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes[J]. Science,1997,275(10):218.

[4] PAVAN A R, SILVA G D, JORNADA D H, et al.Unraveling the anticancer effect of curcumin and resveratrol[J]. Nutrients,2016,8(11):628.

[5] 赖丽琴,魏红权.白藜芦醇对人结肠癌细胞增殖、凋亡以及细胞周期的影响研究[J].浙江中医杂志,2016,51(7):488.

[6] LIU B, ZHOU Z, ZHOU W, et al. Resveratrol inhibits proliferation in human colorectal carcinoma cells by inducing G1/S phase cell cycle arrest and apoptosis through caspase/cyclin CDK pathways[J]. Mol Med Rep,2014,10(4):1697.

[7] WOLTER F,ULRICH S,STEIN J. Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in colorectal cancer:key role of polyamines? [J]. J Nutr,2004,134(12):3219.

[8] GOMEZ L S, ZANCAN P, MARCONDES M C,et al. Resveratrol decreases breast cancer cell viability and glucose metabolism by inhibiting 6-phosphofructo-1-kinase[J]. Biochimie,2013,95(6):1336.

[9] WARBURG O.On respiratory impairment in cancer cells[J]. Science,1956,124(3215):267.

[10] SAUNIER E, ANTONIO S, REGAZZETTI A,et al. Resveratrol reverses the Warburg effect by targeting the pyruvate dehydrogenase complex in colon cancer cells[J]. Sci Rep,2017,7(1):6945.

[11] SOLEAS G J, GOLDBERG D M, GRASS L, et al. Do wine polyphenols modulate p53 gene expression in human cancer cell lines[J]. Clin Biochem,2001,34(5):415.

[12] MAHYAR-ROEMER M,KATSEN A,MESTRES P,et al.Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation,mitochondrial proliferation and membrane potential collapse[J]. Int J Cancer,2001,94(5):615.

[13] BRUNELLE J K,LETAI A. Control of mitochondrial apoptosis by the bcl-2 family[J].J Cell Sci,2009,122(Pt 4):437.

[14] KRAJEWSHI S,KRAJEWSHI M,SHAHAIK A,et al. Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2[J]. Am J Pathol,1994,145(6):1323.

[15] AND?LOV H, RUDOLF E, ERVINKA M. In vitro antiproliferative effects of sulforaphane on human colon cancer cell line sw620[J].Acta Medica (Hradec Kralove), 2007,50(3):171.

[16] 王子元,孙筱婷,赵刚,等.白藜芦醇对人大肠癌耐药细胞增殖及凋亡的影响[J].上海中医药大学学报,2017,31(3):51.

[17] DELMAS D,REBE C,MICHEAU O,et al. Redistribution of cd95,dr4 and dr5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells[J]. Oncogene, 2004,23(55):8979.

[18] DELMAS D,REBE C,LACOUR S,et al. Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells[J]. J Biol Chem,2003,278(42):41482.

[19] 杨君,刘军权,费素娟.白藜芦醇抑制结肠癌干细胞增殖并增强MICA/B的表达[J].细胞与分子免疫学杂志,2015,31(7):889.

[20] CARTER L G, D’ORAZIO J A, PEARSON K J. Resveratrol and cancer: focus on in vivo evidence[J]. Endocr Relat Cancer,2014,21(3):R209.

[21] MOUSA S S,MOUSA S S,MOUSA S A. Effect of resveratrol on angiogenesis and platelet/fibrin-accelerated tumor growth in the chick chorioallantoic membrane model[J]. Nutr Cancer,2005,52(1):59.

[22] KAMA L, ZAIDI F, BHAT R. Resveratrol interferes with an early step in the fibrillization pathway of human lysozyme and modulates it towards less-toxic, off-pathway aggregates[J]. Chembiochem,2018,19(2):159.

[23] ACLOQUE H, ADAMS M S, NIETO M A, et al. Epithelial-mesenchymal transitions in development and disease[J].Cell,2009,139(5):871.

[24] CHAFFER C L, WEINBERG R A. A perspective on cancer cell metastasis[J]. Science,2011,331(6024):1559.

[25] JI Q , LIU X , HAN Z , et al. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-1/Smads signaling pathway mediated Snail/E-cadherin expression[J]. BMC Cancer,2015,15(1),97.

[26] FERLAY J,SHIN H R,BRAY F,et al.Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010,127(12):2893.

[27] CUNNINGHAM D, ATKIN W, LENZ H J, et al. Colorectal cancer[J]. Lancet, 2010,375(9719) :1030.

[28] TRIANTAFILLIDIS J K,NASIOULAS G,KOSMIDIS P A.Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies[J].Anticancer Res,2009,29(7):2727.

[29] 崔文明,赵丽娟,杜海方,等.白藜芦醇对结肠癌细胞生长的影响及作用机制探讨[J].癌变畸变突变,2007,19(6):460.

[30] CUI X, JIN Y, HOFSETH A B, et al.Resveratrol suppresses colitis and colon cancer associated with colitis[J]. Cancer Prev Res (Phila),2010,3(4):549.

[31] GONG W H, ZHAO N, ZHANG Z M,et al.The inhibitory effect of resveratrol on cox-2 expression in human colorectal cancer: a promising therapeutic strategy[J].Eur Rev Med Pharmacol Sci,2017,21(5):1136.

[32] BENNS M, CARR B, KALLAN M J, et al. Benchmarking the incidence of organ failure after injury at trauma centers and nontrauma centers in the United States[J]. J Trauma Acute Care Surg, 2013,75(3):426.

[33] De OLIVEIRA M R, NABAVI S F, MANAYI A, et al. Resveratrol and the mitochondria:from triggering the intrinsic apoptotic pathway to inducing mitochondrial biogenesis,a mechanistic view[J]. Biochim Biophys Acta,2016,1860(4):727.

[34] BALLAK S B, JASPERS R T, DELDICQUE L, et al. Blunted hypertrophic response in old mouse muscle is associated with a lower satellite cell density and is not alleviated by resveratrol[J]. Exp Gerontol,2015,62(1):23.

[35] ARIN E C, YILMAZ D, BOZCAARMUTLU A. Mechanism of inhibition of cpy1a1 and glutathione s-transferase activities in fish liver by quercetin,resveratrol,naringenin,hesperidin,and rutin[J]. Nutr Cancer,2015,67(1):137.

[36] MATTISON J A,WANG M, BERNIER M, et al. Resveratrol prevents high fat/sucrose diet-induced central arterial wall inflammation and stiffening in nonhuman primates[J]. Cell Metab,2014,20(1):183.

[37] SUN Y, WANG H, LIU M, et al.Resveratrol abrogates the effects of hypoxia on cell proliferation,invasion and emt in osteosarcoma cells through downregulation of the hif-1α protein[J].Mol Med Rep,2015,11(3):1975.

[38] DAS D, PREET R, MOHAPATRA P,et al. 1,3-Bis(2-chloroethyl)-1-nitrosourea enhances the inhibitory effect of resveratrol on 5-fluorouracil sensitive/resistant colon cancer cells[J].World J Gastroenterol, 2013,19(42):7374.

[39] 王子元,程卓安,殷佩浩.白藜芦醇逆转肿瘤多药耐药的研究进展[J].中国临床药理学与治疗学,2014,19(6):717.

[40] HUANG F,WU X N,CHEN J,et al. Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells[J]. Exp Ther Med,2014,7(6):1611.

[41] SANLI T,LIU C,RASHID A,et al. Lovastatin sensitizes lung cancer cells to ionizing radiation:modulation of molecular pathways of radioresistance and tumor suppression[J].J Thorac Oncol,2011,6(3):439.

[42] RATTAN R,GRAHAM R P,MAGUIRE J L,et al. Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo[J]. Neoplasia,2011,13(5):483.

[43] WOODARD J,JOSHI S,VIOLLET B,et al. AMPK as a therapeutic target in renal cell carcinoma[J].Cancer Biol Ther,2010,10(11):1168.

[44] 王子元,王荟,吴丽莉,等. AMPK-α/NF-κB信号转导通路在大肠癌多药耐药中的作用及白藜芦醇的干预机制[J].中华中医药杂志,2017,32(7):3266.

[45] PARKDG. Antichemosensitizing effect of resveratrol in cotreatment with oxaliplatin in hct116 colon cancer cell[J]. Ann Surg Treat Res, 2014,86(2):68.

[46] PATEL K R, SCOTT E , BROWN V A , et al. Clinical trials of resveratrol[J].Ann N Y Acad Sci,2011,1215(1):161.

[47] CHOW H S, GARLAND L, HSU C H,et al. Resveratrol modulates drug-and carcinogen-metabolizing enzymes in a healthy volunteer study[J]. Cancer Prev Res(Phila),2010,3(9):1168.

[48] GESCHER A, STEWARD W P, BROWN K .Resveratrol in the management of human cancer: how strong is the clinical evidence?[J]. Ann N Y Acad Sci,2013,1290(1):12.

[49] íLHAMI G. Antioxidant properties of resveratrol: a structure-activity in sight[J]. Innov Food Sci Emerg,2010,11(1):210.

[50] SMOLIGA J M, BLANCHARD O. Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution?[J]. Molecules,2014,19(11):17154.

[51] AIRES V,LIMAGNE E, COTTE A K, et al. Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death[J]. Mol Nutr Food Res,2013,57(7):1170.

[52] OKAMOTO H,MATSUKAWA T, DOI S, et al.A novel resveratrol derivative selectively inhibits the proliferation of colorectal cancer cells with kras mutation[J]. Mol Cell Biochem,2018,442(1-2):39.

[53] WANG S, SU R, NIE S, et al. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals[J]. J Nutr Biochem,2014,25(4):363.

[54] KANG O H, KIM S B, SEO Y S, et al.Curcumin decreases oleic acid-induced lipid accumulation via ampk phosphorylation in hepatocarcinoma cells[J].Eur Rev Med Pharmacol Sci,2013,17(19):2578.

[55] FENG M, ZHONG L X, ZHAN Z Y,et al. Enhanced antitumor efficacy of resveratrol-loaded nanocapsules in colon cancer cells: physicochemical and biological characterization[J].Eur Rev Med Pharmacol Sci,2017,21(2):375.